Sigui Li

1.2k total citations · 2 hit papers
24 papers, 852 citations indexed

About

Sigui Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Sigui Li has authored 24 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Sigui Li's work include Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Maternal Mental Health During Pregnancy and Postpartum (4 papers). Sigui Li is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Maternal Mental Health During Pregnancy and Postpartum (4 papers). Sigui Li collaborates with scholars based in United States, Australia and Italy. Sigui Li's co-authors include Peter Mauch, Barbara Silver, Andrea K. Ng, James Doherty, Donna Neuberg, Hua Ling, Richard D. Gelber, Samantha Meltzer‐Brody, Alan S. Coates and Robert Lasser and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Sigui Li

22 papers receiving 831 citations

Hit Papers

Effect of Zuranolone vs Placebo in Postpartum Depression 2021 2026 2022 2024 2021 2023 40 80 120

Peers

Sigui Li
Reginald Marsh New Zealand
Haide Qin China
Peter F. Bruning Netherlands
Ali Şengül Türkiye
Betty Smoot United States
Sandra C. Steinhorn United States
Sigui Li
Citations per year, relative to Sigui Li Sigui Li (= 1×) peers Tomoko Yamazaki

Countries citing papers authored by Sigui Li

Since Specialization
Citations

This map shows the geographic impact of Sigui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigui Li more than expected).

Fields of papers citing papers by Sigui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sigui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigui Li. The network helps show where Sigui Li may publish in the future.

Co-authorship network of co-authors of Sigui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Sigui Li. A scholar is included among the top collaborators of Sigui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sigui Li. Sigui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Deligiannidis, Kristina M., Samantha Meltzer‐Brody, Marlene P. Freeman, et al.. (2023). Zuranolone for the Treatment of Postpartum Depression. American Journal of Psychiatry. 180(9). 668–675. 93 indexed citations breakdown →
3.
Deligiannidis, Kristina M., et al.. (2023). Improvement in HAMD-17 Subscale Scores With 14-Day Treatment Course of Zuranolone in Postpartum Depression: Results From the SKYLARK Study [ID: 1372313]. Obstetrics and Gynecology. 141(5S). 64S–65S. 1 indexed citations
5.
Deligiannidis, Kristina M., Samantha Meltzer‐Brody, Handan Gunduz‐Bruce, et al.. (2021). Effect of Zuranolone vs Placebo in Postpartum Depression. JAMA Psychiatry. 78(9). 951–951. 149 indexed citations breakdown →
6.
Koenig, Aaron, Harald Murck, Yingchun Luo, et al.. (2020). Using a Multimodal Biomarker Approach to Identify Functional Target Engagement of the Novel NMDA Positive Allosteric Modulator SAGE-718 (1944). Neurology. 94(15_supplement). 1 indexed citations
7.
Bullock, Amy, Inder Kaul, Sigui Li, et al.. (2020). Zuranolone as an oral adjunct to treatment of Parkinsonian tremor: A phase 2, open-label study. Journal of the Neurological Sciences. 421. 117277–117277. 19 indexed citations
8.
Deligiannidis, Kristina M., Ellison Suthoff, Sarah Acaster, et al.. (2020). Effect of SAGE-217 on Anxiety Outcomes in Postpartum Depression in a Randomized, Placebo-Controlled Trial. Biological Psychiatry. 87(9). S278–S279.
9.
Ng, Andrea K., Sigui Li, Christopher J. Recklitis, et al.. (2008). Health Practice in Long-Term Survivors of Hodgkin's Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 71(2). 468–476. 14 indexed citations
10.
Costa, Daniel B., Sigui Li, Olivier Kocher, et al.. (2007). Immunohistochemical analysis of C/EBPα in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: A correlative study of E3590. Lung Cancer. 56(1). 97–103. 17 indexed citations
11.
Cmelak, Anthony J., Sigui Li, Meredith A. Goldwasser, et al.. (2007). Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399. Journal of Clinical Oncology. 25(25). 3971–3977. 115 indexed citations
12.
Masters, Gregory A., Sigui Li, Afshin Dowlati, et al.. (2006). A Phase II Trial of Carboplatin and Gemcitabine with Exisulind (IND #65,056) in Patients with Advanced Non-small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (E1501). Journal of Thoracic Oncology. 1(7). 673–678. 7 indexed citations
13.
Bellucci, Roberto, Sabine Oertelt‐Prigione, Sigui Li, et al.. (2006). Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis. Blood. 109(5). 2001–2007. 9 indexed citations
14.
Colleoni, Marco, Sigui Li, Richard D. Gelber, et al.. (2005). Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index. The Lancet. 366(9491). 1108–1110. 105 indexed citations
15.
Guadagnolo, B. Ashleigh, Sigui Li, Donna Neuberg, et al.. (2005). Long-term outcome and mortality trends in early-stage, Grade 1–2 follicular lymphoma treated with radiation therapy. International Journal of Radiation Oncology*Biology*Physics. 64(3). 928–934. 109 indexed citations
16.
Gianni, Lorenzo, Ilaria Panzini, Sigui Li, et al.. (2005). Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer. Cancer. 106(3). 505–513. 43 indexed citations
17.
Zhou, Ping, Andrea K. Ng, Barbara Silver, et al.. (2005). Radiation therapy for orbital lymphoma. International Journal of Radiation Oncology*Biology*Physics. 63(3). 866–871. 41 indexed citations
18.
Ng, Andrea K., et al.. (2004). A randomized phase II trial of amifostine for head and neck irradiation in lymphoma. Seminars in Oncology. 31(6 Suppl 18). 20–24. 1 indexed citations
19.
Silver, Barbara, et al.. (2003). Hodgkin’s disease in elderly patients (≥60): Clinical outcome and treatment strategies. International Journal of Radiation Oncology*Biology*Physics. 56(2). 556–560. 27 indexed citations
20.
Friedberg, Jonathan W., Sigui Li, Helen Kim, et al.. (2003). Oral fludarabine has significant activity in patients with previously untreated chronic lymphocytic leukemia, and leads to increased STAT1 levels in vivo. Leukemia Research. 28(2). 139–147. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026